Page header

Position of the Transparency Council – Shingrix

At its meeting on 18 November 2024, the Transparency Council adopted position No. 124/2024 on the evaluation of Shingrix vaccine in the indication for the prevention of hemiplegia and hemiplegic neuralgia

 

Publication of the position >>